Pediatric Formulations of Select Second Line Drugs for Treating Tuberculosis

NIH RePORTER · NIH · N43 · $299,995 · view on reporter.nih.gov ↗

Abstract

TO DEVELOP LOW-COST, SHELF-STABLE, PATIENT- ADAPTABLE MINI-TABLETS FOR TREATMENT OF TUBERCULOSIS IN PEDIATRICS

Key facts

NIH application ID: 10497086
Project number: 75N93021C00042-0-9999-1
Recipient: VIA THERAPEUTICS, LLC
Principal Investigator: Ashlee D Brunaugh
Activity code: N43
Funding institute: NIH
Fiscal year: 2021
Award amount: $299,995
Award type: —
Project period: 2021-09-03 → 2022-08-31